Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2
RI-MUHC researcher earns Quebec’s highest honour for research in biomedicine
William Foulkes awarded 2020 Wilder Penfield Prize for research in the genetics of breast and ovarian cancer ...
Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds
A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...
Recovering from sleep deprivation: What is the role of astrocytes?
A new RI-MUHC study uses sleep-deprived fruit flies to study regulation of rebound sleep
Dr. Nada Jabado recognized by UBC
International leader in the field of childhood brain cancers receives the Dr. Chew Wei Memorial Prize
Former RI-MUHC trainee named a member of the CIHR’s new nationwide Youth Advisory Council
Congratulations to Wajih Jawhar of the Cancer Research Program!
Gene therapy to restore sight coming to the Montreal Children's Hospital and to Quebec
Dozens of young patients will be among the first in Canada to benefit from this treatment, which improves vision...
RI-MUHC trainee earns prestigious MITACS fellowship
Congratulations to Catherine Argyriou!
Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill
Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery
From silent infection to rapid death: Why are some people more vulnerable to COVID-19?
Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases